0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sexually Transmitted Diseases (STD) Testing Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-25C5846
Home | Market Reports | Health| Reproductive Health
Global Sexually Transmitted Diseases STD Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Sexually Transmitted Diseases (STD) Testing Market Insights, Forecast to 2030

Code: QYRE-Auto-25C5846
Report
December 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sexually Transmitted Diseases (STD) Testing Market Size

The global Sexually Transmitted Diseases (STD) Testing market is projected to grow from US$ 83340 million in 2024 to US$ 100680 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period.

Sexually Transmitted Diseases (STD) Testing Market

Sexually Transmitted Diseases (STD) Testing Market

Sexually Transmitted Diseases (STD) Testing is used to detect all kinds of Sexually Transmitted virus.Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.
Market Analysis and Insights: Global Sexually Transmitted Diseases (STD) Testing Market
The US & Canada market for Sexually Transmitted Diseases (STD) Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Sexually Transmitted Diseases (STD) Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Sexually Transmitted Diseases (STD) Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Sexually Transmitted Diseases (STD) Testing include ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES and BIO-RAD LABORATORIES, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Sexually Transmitted Diseases (STD) Testing is widely used in various fields, such as Laboratory Testing and Point of Care (POC) Testing, etc. Laboratory Testing provides greatest supports to the Sexually Transmitted Diseases (STD) Testing industry development. In 2023, global % revenue of Sexually Transmitted Diseases (STD) Testing went into Laboratory Testing filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Sexually Transmitted Diseases (STD) Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sexually Transmitted Diseases (STD) Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sexually Transmitted Diseases (STD) Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sexually Transmitted Diseases (STD) Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sexually Transmitted Diseases (STD) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sexually Transmitted Diseases (STD) Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Sexually Transmitted Diseases (STD) Testing Market Report

Report Metric Details
Report Name Sexually Transmitted Diseases (STD) Testing Market
Accounted market size in 2024 US$ 83340 in million
Forecasted market size in 2030 US$ 100680 million
CAGR 3.2
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Laboratory Testing
  • Point of Care (POC) Testing
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES, BIO-RAD LABORATORIES, DIASORIN
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Sexually Transmitted Diseases (STD) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sexually Transmitted Diseases (STD) Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sexually Transmitted Diseases (STD) Testing revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Sexually Transmitted Diseases (STD) Testing Market growing?

Ans: The Sexually Transmitted Diseases (STD) Testing Market witnessing a CAGR of 3.2 during the forecast period 2025-2030.

What is the Sexually Transmitted Diseases (STD) Testing Market size in 2030?

Ans: The Sexually Transmitted Diseases (STD) Testing Market size in 2030 will be US$ 100680 million.

Who are the main players in the Sexually Transmitted Diseases (STD) Testing Market report?

Ans: The main players in the Sexually Transmitted Diseases (STD) Testing Market are ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES, BIO-RAD LABORATORIES, DIASORIN

What are the Application segmentation covered in the Sexually Transmitted Diseases (STD) Testing Market report?

Ans: The Applications covered in the Sexually Transmitted Diseases (STD) Testing Market report are Laboratory Testing, Point of Care (POC) Testing

What are the Type segmentation covered in the Sexually Transmitted Diseases (STD) Testing Market report?

Ans: The Types covered in the Sexually Transmitted Diseases (STD) Testing Market report are Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, Others

Recommended Reports

STD Diagnostics

Infectious Disease Testing

Viral Disease Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chlamydia
1.2.3 Syphilis
1.2.4 Gonorrhea
1.2.5 Herpes Simplex Virus
1.2.6 Human Papilloma Virus
1.2.7 Human Immunodeficiency Virus
1.2.8 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Laboratory Testing
1.3.3 Point of Care (POC) Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases (STD) Testing Market Perspective (2019-2030)
2.2 Global Sexually Transmitted Diseases (STD) Testing Growth Trends by Region
2.2.1 Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Size by Region (2019-2024)
2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2025-2030)
2.3 Sexually Transmitted Diseases (STD) Testing Market Dynamics
2.3.1 Sexually Transmitted Diseases (STD) Testing Industry Trends
2.3.2 Sexually Transmitted Diseases (STD) Testing Market Drivers
2.3.3 Sexually Transmitted Diseases (STD) Testing Market Challenges
2.3.4 Sexually Transmitted Diseases (STD) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sexually Transmitted Diseases (STD) Testing by Players
3.1.1 Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2019-2024)
3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sexually Transmitted Diseases (STD) Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2023
3.5 Global Key Players of Sexually Transmitted Diseases (STD) Testing Head office and Area Served
3.6 Global Key Players of Sexually Transmitted Diseases (STD) Testing, Product and Application
3.7 Global Key Players of Sexually Transmitted Diseases (STD) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2019-2024)
4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2025-2030)
5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Application (2019-2024)
5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
6.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type
6.2.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
6.2.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030)
6.2.3 North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application
6.3.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
6.3.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030)
6.3.3 North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country
6.4.1 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
6.4.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
7.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type
7.2.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
7.2.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030)
7.2.3 Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application
7.3.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
7.3.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030)
7.3.3 Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country
7.4.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
7.4.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
8.2 China Sexually Transmitted Diseases (STD) Testing Market Size by Type
8.2.1 China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
8.2.2 China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030)
8.2.3 China Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
8.3 China Sexually Transmitted Diseases (STD) Testing Market Size by Application
8.3.1 China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
8.3.2 China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030)
8.3.3 China Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
9.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type
9.2.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
9.2.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030)
9.2.3 Asia Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
9.3 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application
9.3.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
9.3.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030)
9.3.3 Asia Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
9.4 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region
9.4.1 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2019-2024)
9.4.3 Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ROCHE HOLDINGS
11.1.1 ROCHE HOLDINGS Company Details
11.1.2 ROCHE HOLDINGS Business Overview
11.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
11.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.1.5 ROCHE HOLDINGS Recent Developments
11.2 BIOMERIEUX
11.2.1 BIOMERIEUX Company Details
11.2.2 BIOMERIEUX Business Overview
11.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
11.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.2.5 BIOMERIEUX Recent Developments
11.3 HOLOGIC
11.3.1 HOLOGIC Company Details
11.3.2 HOLOGIC Business Overview
11.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
11.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.3.5 HOLOGIC Recent Developments
11.4 BECTON DICKINSON
11.4.1 BECTON DICKINSON Company Details
11.4.2 BECTON DICKINSON Business Overview
11.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
11.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.4.5 BECTON DICKINSON Recent Developments
11.5 ORASURE
11.5.1 ORASURE Company Details
11.5.2 ORASURE Business Overview
11.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
11.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.5.5 ORASURE Recent Developments
11.6 DANAHER
11.6.1 DANAHER Company Details
11.6.2 DANAHER Business Overview
11.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
11.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.6.5 DANAHER Recent Developments
11.7 AFFYMETRIX
11.7.1 AFFYMETRIX Company Details
11.7.2 AFFYMETRIX Business Overview
11.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
11.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.7.5 AFFYMETRIX Recent Developments
11.8 ABBOTT LABORATORIES
11.8.1 ABBOTT LABORATORIES Company Details
11.8.2 ABBOTT LABORATORIES Business Overview
11.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.8.5 ABBOTT LABORATORIES Recent Developments
11.9 BIO-RAD LABORATORIES
11.9.1 BIO-RAD LABORATORIES Company Details
11.9.2 BIO-RAD LABORATORIES Business Overview
11.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.9.5 BIO-RAD LABORATORIES Recent Developments
11.10 DIASORIN
11.10.1 DIASORIN Company Details
11.10.2 DIASORIN Business Overview
11.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
11.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.10.5 DIASORIN Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chlamydia
    Table 3. Key Players of Syphilis
    Table 4. Key Players of Gonorrhea
    Table 5. Key Players of Herpes Simplex Virus
    Table 6. Key Players of Human Papilloma Virus
    Table 7. Key Players of Human Immunodeficiency Virus
    Table 8. Key Players of Others
    Table 9. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 10. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Sexually Transmitted Diseases (STD) Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2019-2024)
    Table 13. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region (2025-2030)
    Table 15. Sexually Transmitted Diseases (STD) Testing Market Trends
    Table 16. Sexually Transmitted Diseases (STD) Testing Market Drivers
    Table 17. Sexually Transmitted Diseases (STD) Testing Market Challenges
    Table 18. Sexually Transmitted Diseases (STD) Testing Market Restraints
    Table 19. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Players (2019-2024)
    Table 21. Global Top Sexually Transmitted Diseases (STD) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2023)
    Table 22. Global Sexually Transmitted Diseases (STD) Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 23. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Global Key Players of Sexually Transmitted Diseases (STD) Testing, Headquarters and Area Served
    Table 25. Global Key Players of Sexually Transmitted Diseases (STD) Testing, Product and Application
    Table 26. Global Key Players of Sexually Transmitted Diseases (STD) Testing, Product and Application
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2019-2024)
    Table 30. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2025-2030)
    Table 32. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Application (2019-2024)
    Table 34. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Application (2025-2030)
    Table 36. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 37. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 38. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 39. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 40. North America Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 42. North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 44. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 45. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 46. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 47. Europe Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 50. China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 51. China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 52. China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 53. China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 55. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 56. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 57. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 58. Asia Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 59. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 60. Asia Sexually Transmitted Diseases (STD) Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 66. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 68. ROCHE HOLDINGS Company Details
    Table 69. ROCHE HOLDINGS Business Overview
    Table 70. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product
    Table 71. ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 72. ROCHE HOLDINGS Recent Developments
    Table 73. BIOMERIEUX Company Details
    Table 74. BIOMERIEUX Business Overview
    Table 75. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product
    Table 76. BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 77. BIOMERIEUX Recent Developments
    Table 78. HOLOGIC Company Details
    Table 79. HOLOGIC Business Overview
    Table 80. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product
    Table 81. HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 82. HOLOGIC Recent Developments
    Table 83. BECTON DICKINSON Company Details
    Table 84. BECTON DICKINSON Business Overview
    Table 85. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product
    Table 86. BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 87. BECTON DICKINSON Recent Developments
    Table 88. ORASURE Company Details
    Table 89. ORASURE Business Overview
    Table 90. ORASURE Sexually Transmitted Diseases (STD) Testing Product
    Table 91. ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 92. ORASURE Recent Developments
    Table 93. DANAHER Company Details
    Table 94. DANAHER Business Overview
    Table 95. DANAHER Sexually Transmitted Diseases (STD) Testing Product
    Table 96. DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 97. DANAHER Recent Developments
    Table 98. AFFYMETRIX Company Details
    Table 99. AFFYMETRIX Business Overview
    Table 100. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product
    Table 101. AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 102. AFFYMETRIX Recent Developments
    Table 103. ABBOTT LABORATORIES Company Details
    Table 104. ABBOTT LABORATORIES Business Overview
    Table 105. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
    Table 106. ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 107. ABBOTT LABORATORIES Recent Developments
    Table 108. BIO-RAD LABORATORIES Company Details
    Table 109. BIO-RAD LABORATORIES Business Overview
    Table 110. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product
    Table 111. BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 112. BIO-RAD LABORATORIES Recent Developments
    Table 113. DIASORIN Company Details
    Table 114. DIASORIN Business Overview
    Table 115. DIASORIN Sexually Transmitted Diseases (STD) Testing Product
    Table 116. DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024) & (US$ Million)
    Table 117. DIASORIN Recent Developments
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Sexually Transmitted Diseases (STD) Testing Market Share by Type: 2023 VS 2030
    Figure 3. Chlamydia Features
    Figure 4. Syphilis Features
    Figure 5. Gonorrhea Features
    Figure 6. Herpes Simplex Virus Features
    Figure 7. Human Papilloma Virus Features
    Figure 8. Human Immunodeficiency Virus Features
    Figure 9. Others Features
    Figure 10. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2023 VS 2030
    Figure 12. Laboratory Testing Case Studies
    Figure 13. Point of Care (POC) Testing Case Studies
    Figure 14. Sexually Transmitted Diseases (STD) Testing Report Years Considered
    Figure 15. Global Sexually Transmitted Diseases (STD) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Sexually Transmitted Diseases (STD) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Region: 2023 VS 2030
    Figure 18. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players in 2023
    Figure 19. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2023
    Figure 21. North America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
    Figure 23. North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
    Figure 24. North America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2019-2030)
    Figure 25. United States Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Sexually Transmitted Diseases (STD) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
    Figure 29. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
    Figure 30. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Country (2019-2030)
    Figure 31. Germany Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Sexually Transmitted Diseases (STD) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
    Figure 39. China Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
    Figure 40. Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
    Figure 42. Asia Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
    Figure 43. Asia Sexually Transmitted Diseases (STD) Testing Market Share by Region (2019-2030)
    Figure 44. Japan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Testing Market Share by Country (2019-2030)
    Figure 54. Brazil Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. ROCHE HOLDINGS Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 61. BIOMERIEUX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 62. HOLOGIC Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 63. BECTON DICKINSON Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 64. ORASURE Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 65. DANAHER Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 66. AFFYMETRIX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 67. ABBOTT LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 68. BIO-RAD LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 69. DIASORIN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS